Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New taxane analogue shows potential as an orally active alternative to paclitaxel

April 16, 1999

Vion presents parent and prodrug ribonucleotide reductase inhibitors at AACR

April 16, 1999

EntreMed paves the way for clinical evaluation of recombinant human Endostatin

April 16, 1999

Korean researchers report preclinical toxicity and pharmacokinetics of CKD-602 continuous infusion

April 16, 1999

In vitro and in vivo profile of AG-7352 described in further detail at AACR meeting

April 16, 1999

Pharmacokinetics and MTD of BBR-2778 determined in cancer patients

April 16, 1999

Differentiation-inducing vitamin D derivatives described by Teikoku Hormone

April 16, 1999

News from AACR: chemopreventive properties of NSAIDs, including COX-2 inhibitors

April 16, 1999

Celsion signs option agreement for cancer therapy technology

April 16, 1999

New distamycin derivative PNU-166196 exerts both antiproliferative and apoptotic effects

April 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...